Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Beta-blockers in hypertension: truths and half-truths.

× No keyword cloud information.

49 in total

1. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Authors: L Hansson; L H Lindholm; L Niskanen; J Lanke; T Hedner; A Niklason; K Luomanmäki; B Dahlöf; U de Faire; C Mörlin; B E Karlberg; P O Wester; J E Björck
Journal: Lancet Date: 1999-02-20 Impact factor: 79.321

Review 2. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Authors: Lars Hjalmar Lindholm; Bo Carlberg; Ola Samuelsson
Journal: Lancet Date: 2005 Oct 29-Nov 4 Impact factor: 79.321

3. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.

Authors: Sripal Bangalore; Sanobar Parkar; Ehud Grossman; Franz H Messerli
Journal: Am J Cardiol Date: 2007-08-10 Impact factor: 2.778

4. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.

Authors: R E Schmieder; P Martus; A Klingbeil
Journal: JAMA Date: 1996-05-15 Impact factor: 56.272

5. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.

Authors: Willem J Remme; Christian Torp-Pedersen; John G F Cleland; Philip A Poole-Wilson; Marco Metra; Michel Komajda; Karl Swedberg; Andrea Di Lenarda; Phillip Spark; Armin Scherhag; Christine Moullet; Mary Ann Lukas
Journal: J Am Coll Cardiol Date: 2007-02-20 Impact factor: 24.094

6. Carvedilol inhibits endothelin-1 biosynthesis in cultured human coronary artery endothelial cells.

Authors: E H Ohlstein; A J Arleth; B Storer; A M Romanic
Journal: J Mol Cell Cardiol Date: 1998-01 Impact factor: 5.000

7. Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.

Authors: T Baba; S Murabayashi; T Tomiyama; K Takebe
Journal: Eur J Clin Pharmacol Date: 1990 Impact factor: 2.953

8. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group.

Authors:
Journal: J Hypertens Date: 1985-08 Impact factor: 4.844

Review 9. Use of beta-blockers in obesity hypertension: potential role of weight gain.

Authors: T Pischon; A M Sharma
Journal: Obes Rev Date: 2001-11 Impact factor: 9.213

10. Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.

Authors: Daniela Dobre; Dirk J van Veldhuisen; Giacomo Mordenti; Marius Vintila; Flora M Haaijer-Ruskamp; Andrew J S Coats; Philip A Poole-Wilson; Marcus D Flather
Journal: Am Heart J Date: 2007-07 Impact factor: 4.749